Nurse Anesthetist - CR in Calais, ME Accepting Medicare

8 Nurse Anesthetist - CR nurses found. Showing 1 - 8

Devon D Brooks, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ln, Calais, ME 04619 Phone: 207-454-7521

Katherine B Kincer, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ln, Calais, ME 04619 Phone: 910-642-8011    Fax: 910-642-9328

Mr. Manuel A Falcon, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ln, Calais, ME 04619 Phone: 207-454-7521

David C Brilliott, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 22 Hospital Ln, Calais, ME 04619 Phone: 207-454-7521    Fax: 207-454-3616

Nicholas S Quinton, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ln, Calais, ME 04619 Phone: 207-454-7521    Fax: 207-454-9247

Marisela Morillo, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ln, Calais, ME 04619 Phone: 207-214-8045

Robert Charles Rogers, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 22 Hospital Ln, Calais, ME 04619 Phone: 207-454-7521    Fax: 207-454-3616

Ruth Jahn, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ln, Calais, ME 04619 Phone: 207-454-7521    Fax: 207-795-2766

News Archive

NovaBay's Aganocide compounds effective against multidrug-resistant bacteria

NovaBay(R) Pharmaceuticals, Inc. (NYSE-AMEX: NBY) (http://www.novabaypharma.com), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, presented in two poster sessions today at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.

First Edition: October 29, 2013

Today's headlines include previews of a Capitol Hill hearing that will feature Centers for Medicare & Medicaid Serivces Administrator Marilyn Tavenner.

Experts discuss potential of maintaining cognitive function through dietary intake

Aging is a highly complex process marked by a succession of events that may lead to an altered brain function, including neurodegenerative diseases. To date, the precise cause of cognitive decline remains quite elusive.

Ipsen's Somatuline CLARINET Phase III study published online in NEJM

The U.S. affiliate of Ipsen today announced that the New England Journal of Medicine has published clinical trial results showing that Somatuline Autogel / Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) achieved statistically significant prolongation of progression free survival (PFS) over placebo in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Read more Medical News

› Verified 9 days ago